Skip to content
NBY NovaBay Pharmaceuticals, Inc.
$0.00 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy NBY stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 2.6M
Enterprise value 3M
Trailing PE -0.0038239536175308
Forward PE -0.6412195
PEG Ratio -0.6412195
Enterprise to EBITDA -0.589
Enterprise to revenue 0.226
Price to book MRQ 2.4119265
Price to sales TTM 0.19669947

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 13.1M
EBITDA -5018000
Diluted EPS TTM -74.61
Total Cash (MRQ) 776K
Current ratio (MRQ) 1.149
Operating Cash Flow (TTM) -4731000

NBY trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent NBY News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.